chevron_leftBack
As of 24 April 2025, Alpha Tau Medical Ltd. has a market cap of $187.92M USD, ranking #17496 globally and #38 in Israel. It ranks #1745 in the Healthcare sector, and #491 in the Biotechnology industry.
Key Stats
Market Cap
$187.92MUSD
Enterprise Value
$140.85MUSD
EBITDA (TTM)
-$34.94MUSD
Net Income (TTM)
-$31.75MUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Uzi Sofer
open_in_new
Employees
125
Founded
2015
Website
alphatau.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.4% | 4% | 0.8% | -34% | 19% | 7.8% |
Upcoming Earnings
Earnings Date
Mon, May 19
Earnings Time
bedtime
After Close
EPS Estimate
-$0.1300
Revenue Estimate
-
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
DRTS
Alpha Tau Medical Ltd
ISIN: IL0011839383
Shares Out.:
Shares Outstanding:
70.381M1
Shares Float:
51.989M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.63 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
